吉電股份(000875.SZ)委託實控人開展資產證券化融資業務
格隆匯12月10日丨吉電股份(000875.SZ)公佈,公司實際控制人——國家電力投資集團有限公司(“集團公司”)作為發行主體,向上交所、銀行間交易市場協會申請發行ABS、ABN,註冊儲架各100億元,發行額度合計100億元,發行期限3年。由平安證券設立並管理的國家可再生能源電價附加補助資產支持專項計劃,集團公司與其簽訂基礎資產買賣協議。募集資金用於滿足相關提供應收賬款資產子公司的資金需求。
公司同意委託集團公司開展資產證券化融資業務,委託代理的資產規模為15.83億元,期限3年,集團公司不收取委託費用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.